Dolby Laboratories (NYSE:DLB) is set to give its latest quarterly earnings report on Thursday, 2026-01-29. Here's what investors need to know before the announcement.

Analysts estimate that Dolby Laboratories will report an earnings per share (EPS) of $0.84.

The market awaits Dolby Laboratories's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Historical Earnings Performance

Last quarter the company beat EPS by $0.39, which was followed by a 0.06% increase in the share price the next day.

Here's a look at Dolby Laboratories's past performance and the resulting price change:

Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025
EPS Estimate	0.60	0.61	1.27	0.98
EPS Actual	0.99	0.78	1.34	1.14
Price Change %	0.00	-7.00	-2.00	8.00

Dolby Laboratories Share Price Analysis

Shares of Dolby Laboratories were trading at $61.36 as of January 27. Over the last 52-week period, shares are down 29.95%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Views on Dolby Laboratories

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Dolby Laboratories.

The consensus rating for Dolby Laboratories is Buy, based on 4 analyst ratings. With an average one-year price target of $88.75, there's a potential 44.64% upside.

Comparing Ratings Among Industry Peers

The analysis below examines the analyst ratings and average 1-year price targets of GitLab, Monday.Com and SentinelOne, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.

• Analysts currently favor an Neutral trajectory for GitLab, with an average 1-year price target of $48.73, suggesting a potential 20.58% downside.
• Analysts currently favor an Buy trajectory for Monday.Com, with an average 1-year price target of $236.62, suggesting a potential 285.63% upside.
• Analysts currently favor an Neutral trajectory for SentinelOne, with an average 1-year price target of $20.57, suggesting a potential 66.48% downside.

Comprehensive Peer Analysis Summary

Within the peer analysis summary, vital metrics for GitLab, Monday.Com and SentinelOne are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

Company	Consensus	Revenue Growth	Gross Profit	Return on Equity
Dolby Laboratories	Buy	0.73%	$267.50M	1.89%
GitLab	Neutral	24.64%	$212.13M	-0.93%
Monday.Com	Buy	26.24%	$281.07M	1.06%
SentinelOne	Neutral	22.91%	$191.06M	-3.94%

Key Takeaway:

Dolby Laboratories ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Consensus rating and Return on Equity.

About Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Financial Milestones: Dolby Laboratories's Journey

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Dolby Laboratories's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.73% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: Dolby Laboratories's net margin is impressive, surpassing industry averages. With a net margin of 16.07%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Dolby Laboratories's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.89%, the company may face hurdles in achieving optimal financial returns.

Return on Assets (ROA): Dolby Laboratories's ROA excels beyond industry benchmarks, reaching 1.54%. This signifies efficient management of assets and strong financial health.

Debt Management: Dolby Laboratories's debt-to-equity ratio is below the industry average. With a ratio of 0.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

To track all earnings releases for Dolby Laboratories visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.